These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis. Kirstein MM; Book T; Manns MP; von Hahn T; Voigtländer T United European Gastroenterol J; 2020 Jul; 8(6):716-724. PubMed ID: 32366182 [TBL] [Abstract][Full Text] [Related]
5. Liver transplantation for critically Ill patients with secondary sclerosing cholangitis: Outcome and complications. Voigtländer T; Jaeckel E; Lehner F; Manns MP; Lankisch TO Liver Transpl; 2015 Oct; 21(10):1295-9. PubMed ID: 26069199 [TBL] [Abstract][Full Text] [Related]
6. Secondary Sclerosing Cholangitis in Critically Ill Patients: Clinical Presentation, Cholangiographic Features, Natural History, and Outcome: A Series of 16 Cases. Leonhardt S; Veltzke-Schlieker W; Adler A; Schott E; Eurich D; Faber W; Neuhaus P; Seehofer D Medicine (Baltimore); 2015 Dec; 94(49):e2188. PubMed ID: 26656347 [TBL] [Abstract][Full Text] [Related]
7. Secondary Sclerosing Cholangitis After SARS-CoV2: ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients? Bartoli A; Cursaro C; Seferi H; Andreone P Hepat Med; 2023; 15():93-112. PubMed ID: 37547355 [TBL] [Abstract][Full Text] [Related]
8. Secondary Sclerosing Cholangitis due to Severe COVID-19: An Emerging Disease Entity? Seifert M; Kneiseler G; Dechene A Digestion; 2023; 104(4):306-312. PubMed ID: 36889285 [TBL] [Abstract][Full Text] [Related]
10. Abdominal obesity and prolonged prone positioning increase risk of developing sclerosing cholangitis in critically ill patients with influenza A-associated ARDS. Weig T; Schubert MI; Gruener N; Dolch ME; Frey L; Miller J; Johnson T; Irlbeck M Eur J Med Res; 2012 Dec; 17(1):30. PubMed ID: 23259907 [TBL] [Abstract][Full Text] [Related]
11. Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19. Bütikofer S; Lenggenhager D; Wendel Garcia PD; Maggio EM; Haberecker M; Reiner CS; Brüllmann G; Buehler PK; Gubler C; Müllhaupt B; Jüngst C; Morell B Liver Int; 2021 Oct; 41(10):2404-2417. PubMed ID: 34018314 [TBL] [Abstract][Full Text] [Related]
12. Outcome of patients with ischemic-like cholangiopathy with secondary sclerosing cholangitis after liver transplantation. Kirchner GI; Scherer MN; Obed A; Ruemmele P; Wiest R; Froh M; Loss M; Schlitt HJ; Schölmerich J; Gelbmann CM Scand J Gastroenterol; 2011 Apr; 46(4):471-8. PubMed ID: 21114429 [TBL] [Abstract][Full Text] [Related]
13. Kinetics of Bilirubin and Ammonia Elimination during Hemadsorption Therapy in Secondary Sclerosing Cholangitis Following ECMO Therapy and Severe COVID-19. Tampe D; Korsten P; Bremer SCB; Winkler MS; Tampe B Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944657 [TBL] [Abstract][Full Text] [Related]
14. Microbiological analysis of bile and its impact in critically ill patients with secondary sclerosing cholangitis. Voigtländer T; Leuchs E; Vonberg RP; Solbach P; Manns MP; Suerbaum S; Lankisch TO J Infect; 2015 May; 70(5):483-90. PubMed ID: 25659761 [TBL] [Abstract][Full Text] [Related]
15. Endoscopic Characterization and Outcome of COVID-19 Patients with Secondary Sclerosing Cholangitis: A Case Series of a Tertiary Center. Hofstetter P; Zuber-Jerger I; Mehrl A; Graf B; Lunz D; Lubnow M; Müller T; Schmid S; Müller M; Kandulski A J Gastrointestin Liver Dis; 2024 Jun; 33(2):218-225. PubMed ID: 38944874 [TBL] [Abstract][Full Text] [Related]
16. Corona again? SSC after a severe COVID-disease. Arnstadt B; Zillinger C; Treitl M; Allescher HD Z Gastroenterol; 2021 Dec; 59(12):1304-1308. PubMed ID: 34666402 [TBL] [Abstract][Full Text] [Related]
17. Biliary Cast Syndrome and Secondary Sclerosing Cholangitis in Critically Ill Patient after Long-Term Treatment in the Intensive Care Unit. Alkurdi A; Herrmann J; Bikmukhametov D; Tschöpe R Case Rep Gastroenterol; 2024; 18(1):260-265. PubMed ID: 38737441 [TBL] [Abstract][Full Text] [Related]
18. BISCIT: Biliary interventions in critically ill patients with secondary sclerosing cholangitis-a study protocol for a multicenter, randomized, controlled parallel group trial. Stahl K; Klein F; Voigtländer T; Großhennig A; Book T; Müller T; Wree A; Kuellmer A; Weigt J; Dechene A; Wedi E; Kandulski A; Lange CM; Holzwart D; von Witzendorff D; Ringe KI; Wedemeyer H; Heidrich B; Trials; 2023 Mar; 24(1):247. PubMed ID: 37004078 [TBL] [Abstract][Full Text] [Related]
19. Secondary sclerosing cholangitis in critically ill patients: current perspectives. Gudnason HO; Björnsson ES Clin Exp Gastroenterol; 2017; 10():105-111. PubMed ID: 28694703 [TBL] [Abstract][Full Text] [Related]
20. Secondary sclerosing cholangitis in cardiac surgical patients: A complication with a dismal prognosis. Schade I; Radakovic D; Hoffmann J; Sommer SP; Stefenelli U; Schimmer C; Leyh RG; Aleksic I J Thorac Cardiovasc Surg; 2017 Sep; 154(3):906-912. PubMed ID: 28554673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]